All-trans retinoic acid attenuates experimental colitis through inhibition of NF-κB signaling

Immunology Letters

Volumn 162, Issue 1, 2014, Pages 34-40

  Hong, Kai ^a   Zhang, Yi ^a   Guo, Yuan ^a   Xie, Jun ^a   Wang, Jian ^a   He, Xingxing ^a   Lu, Nonghua ^a   Bai, Aiping ^a  

^a NANCHANG UNIVERSITY   (China)

Author keywords

All trans retinoic acid; Colitis; Macrophage; NF B; RAR

Indexed keywords

CD68 ANTIGEN; DEXTRAN SULFATE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LE 135; LIPOPOLYSACCHARIDE; MYELOPEROXIDASE; RETINOIC ACID DERIVATIVE; RETINOIC ACID RECEPTOR; TRANSCRIPTION FACTOR RELA; TUMOR NECROSIS FACTOR; UNCLASSIFIED DRUG; CD68 ANTIGEN, HUMAN; DIFFERENTIATION ANTIGEN; LEUKOCYTE ANTIGEN; PEROXIDASE; RETINOIC ACID;

ADAPTIVE IMMUNITY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN EXPRESSION; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CELL FUNCTION; CONTROLLED STUDY; DISEASE EXACERBATION; ENZYME ACTIVATION; ENZYME INHIBITION; EXPERIMENTAL COLITIS; FEMALE; IMMUNOPATHOGENESIS; IMMUNOREGULATION; IN VITRO STUDY; INNATE IMMUNITY; MACROPHAGE; MOUSE; NONHUMAN; REGULATORY T LYMPHOCYTE; SIGNAL TRANSDUCTION; TH17 CELL; ANIMAL; CELL LINE; CHEMICALLY INDUCED; COLITIS; DISEASE MODEL; DRUG EFFECTS; IMMUNOLOGY; METABOLISM; NEUTROPHIL CHEMOTAXIS; PATHOLOGY;

ANIMALS; ANTIGENS, CD; ANTIGENS, DIFFERENTIATION, MYELOMONOCYTIC; CELL LINE; COLITIS; DEXTRAN SULFATE; DISEASE MODELS, ANIMAL; FEMALE; LIPOPOLYSACCHARIDES; MACROPHAGES; MICE; NEUTROPHIL INFILTRATION; NF-KAPPA B; PEROXIDASE; SIGNAL TRANSDUCTION; TRETINOIN; TUMOR NECROSIS FACTORS;

EID: 84908271093     PISSN: 01652478     EISSN: 18790542     Source Type: Journal    
DOI: 10.1016/j.imlet.2014.06.011     Document Type: Article

References (35)

1. Arseneau K.O., Tamagawa H., Pizarro T.T., Cominelli F. Innate and adaptive immune responses related to IBD pathogenesis. Curr Gastroenterol Rep 2007, 9:508-512.
2. Brown S.J., Mayer L. The immune response in inflammatory bowel disease. Am J Gastroenterol 2007, 102:2058-2069.
3. Yamamoto-Furusho J.K., Podolsky D.K. Innate immunity in inflammatory bowel disease. World J Gastroenterol 2007, 13:5577-5580.
4. Xavier R.J., Podolsky D.K. Unravelling the pathogenesis of inflammatory bowel disease. Nature 2007, 448:427-434.
5. Gasparini C., Feldmann M. NF-kappaB as a target for modulating inflammatory responses. Curr Pharm Des 2012, 18:5735-5745.
6. Rakonczay Z., Hegyi P., Takacs T., McCarroll J., Saluja A.K. The role of NF-kappaB activation in the pathogenesis of acute pancreatitis. Gut 2008, 57:259-267.
7. Ohira H., Fujioka Y., Katagiri C., Mamoto R., Aoyama-Ishikawa M., Amako K., et al. Butyrate attenuates inflammation and lipolysis generated by the interaction of adipocytes and macrophages. J Atheroscler Thromb 2013, 20:425-442.
8. Bai A., Ma A.G., Yong M., Weiss C.R., Ma Y., Guan Q., et al. AMPK agonist downregulates innate and adaptive immune responses in TNBS-induced murine acute and relapsing colitis. Biochem Pharmacol 2010, 80:1708-1717.
9. Bai A., Guo Y., Lu N. The effect of the cholinergic anti-inflammatory pathway on experimental colitis. Scand J Immunol 2007, 66:538-545.
10. Reifen R., Nur T., Ghebermeskel K., Zaiger G., Urizky R., Pines M. Vitamin A deficiency exacerbates inflammation in a rat model of colitis through activation of nuclear factor-kappaB and collagen formation. J Nutr 2002, 132:2743-2747.
11. Long K.Z., Santos J.I., Rosado J.L., Lopez-Saucedo C., Thompson-Bonilla R., Abonce M., et al. Impact of vitamin A on selected gastrointestinal pathogen infections and associated diarrheal episodes among children in Mexico City, Mexico. J Infect Dis 2006, 194:1217-1225.
12. Benson M.J., Pino-Lagos K., Rosemblatt M., Noelle R.J. All-trans retinoic acid mediates enhanced T reg cell growth, differentiation, and gut homing in the face of high levels of co-stimulation. J Exp Med 2007, 204:1765-1774.
13. Elias K.M., Laurence A., Davidson T.S., Stephens G., Kanno Y., Shevach E.M., et al. Retinoic acid inhibits Th17 polarization and enhances FoxP3 expression through a Stat-3/Stat-5 independent signaling pathway. Blood 2008, 111:1013-1020.
14. Mucida D., Park Y., Kim G., Turovskaya O., Scott I., Kronenberg M., et al. Reciprocal TH17 and regulatory T cell differentiation mediated by retinoic acid. Science 2007, 317:256-260.
15. Bai A., Lu N., Guo Y., Liu Z., Chen J., Peng Z. All-trans retinoic acid down-regulates inflammatory responses by shifting the Treg/Th17 profile in human ulcerative and murine colitis. J Leukoc Biol 2009, 86:959-969.
16. Menning A., Loddenkemper C., Westendorf A.M., Szilagyi B., Buer J., Siewert C., et al. Retinoic acid-induced gut tropism improves the protective capacity of Treg in acute but not in chronic gut inflammation. Eur J Immunol 2010, 40:2539-2548.
17. Bai A., Lu N., Guo Y., Chen J., Liu Z. Modulation of inflammatory response via alpha2-adrenoceptor blockade in acute murine colitis. Clin Exp Immunol 2009, 156:353-362.
18. Murano M., Maemura K., Hirata I., Toshina K., Nishikawa T., Hamamoto N., et al. Therapeutic effect of intracolonically administered nuclear factor kappa B (p65) antisense oligonucleotide on mouse dextran sulphate sodium (DSS)-induced colitis. Clin Exp Immunol 2000, 120:51-58.
19. Bai A.P., Ouyang Q., Xiao X.R., Li S.F. Probiotics modulate inflammatory cytokine secretion from inflamed mucosa in active ulcerative colitis. Int J Clin Pract 2006, 60:284-288.
20. Han E.S., Oh J.Y., Park H.J. Cordyceps militaris extract suppresses dextran sodium sulfate-induced acute colitis in mice and production of inflammatory mediators from macrophages and mast cells. J Ethnopharmacol 2011, 134:703-710.
21. D'Haens G. Geert Anti-TNF therapy for Crohn's disease. Curr Pharm Des 2003, 9:289-294.
22. Bradley P.P., Priebat D.A., Christensen R.D., Rothstein G. Measurement of cutaneous inflammation: estimation of neutrophil content with an enzyme marker. J Invest Dermatol 1982, 78:206-209.
23. Harris J.A., Jain S., Ren Q., Zarineh A., Liu C., Ibrahim S. CD163 versus CD68 in tumor associated macrophages of classical Hodgkin lymphoma. Diagn Pathol 2012, 7:12.
24. Miyagawa N., Homma T., Kagechika H., Shudo K., Nagai H. Effect of synthetic retinoid, TAC-101, on experimental autoimmune disease. Pharmacology 2003, 67:21-31.
25. Zunino S.J., Storms D.H., Stephensen C.B. Diets rich in polyphenols and vitamin A inhibit the development of type I autoimmune diabetes in nonobese diabetic mice. J Nutr 2007, 137:1216-1221.
26. Racke M.K., Burnett D., Pak S.H., Albert P.S., Cannella B., Raine C.S., et al. Retinoid treatment of experimental allergic encephalomyelitis. IL-4 production correlates with improved disease course. J Immunol 1995, 154:450-458.
27. Sheikh S.Z., Plevy S.E. The role of the macrophage in sentinel responses in intestinal immunity. Curr Opin Gastroenterol 2010, 26:578-582.
28. Mahida Y.R. The key role of macrophages in the immunopathogenesis of inflammatory bowel disease. Inflamm Bowel Dis 2000, 6:21-33.
29. Scheiffele F., Fuss I.J. Induction of TNBS colitis in mice. Curr Protoc Immunol 2002, Chapter 15:Unit 15.19.
30. Uno J.K., Rao K.N., Matsuoka K., Sheikh S.Z., Kobayashi T., Li F., et al. Altered macrophage function contributes to colitis in mice defective in the phosphoinositide-3 kinase subunit p110delta. Gastroenterology 2010, 139:1642-1653. 1653 e1-6.
31. Fields A.L., Soprano D.R., Soprano K.J. Retinoids in biological control and cancer. J Cell Biochem 2007, 102:886-898.
32. Theodosiou M., Laudet V., Schubert M. From carrot to clinic: an overview of the retinoic acid signaling pathway. Cell Mol Life Sci 2010, 67:1423-1445.
33. Rigas J.R., Dragnev K.H. Emerging role of rexinoids in non-small cell lung cancer: focus on bexarotene. Oncologist 2005, 10:22-33.
34. Mao J.T., Goldin J.G., Dermand J., Ibrahim G., Brown M.S., Emerick A., et al. A pilot study of all-trans-retinoic acid for the treatment of human emphysema. Am J Respir Crit Care Med 2002, 165:718-723.
35. Frankenberger M., Heimbeck I., Moller W., Mamidi S., Kassner G., Pukelsheim K., et al. Inhaled all-trans retinoic acid in an individual with severe emphysema. Eur Respir J 2009, 34:1487-1489.